Skip to main contentSkip to navigation
Sirius Investors

HSAQ Stock: Health Sciences Acquisitions Corporation 2 Stock Price, Analysis & Insights

Get live HSAQ stock price $13.31, comprehensive Health Sciences Acquisitions Corporation 2 stock analysis, charts, news, and expert forecast. Real-time HSAQ stock data and investment insights.

13.31
24.16%Today
HSAQHealth Sciences Acquisitions Corporation 2 • NASDAQ Capital Market • Financial Services
Market Cap
149.23M
Volume
119.61K
52W High
13.80
52W Low
9.41

Loading chart data...

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Health Sciences Acquisitions Corporation 2 currently lacks active business operations. Its primary objective is to complete a strategic business combination, such as a merger or acquisition, with one or more enterprises. These target businesses will ...

Company Information

CEO
Roderick Tze Ian Wong
Sector
Financial Services
Industry
Shell Companies
Employees
N/A

Contact Information

Website
Address
40 10th Avenue
Country
US

Investment Analysis & Business Insights

Financial Services
Shell Companies

Investment Highlights

Strong presence in the Financial Services sector with established market position

Lower volatility stock (Beta: 0.00) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Health Sciences Acquisitions Corporation 2 shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Financial Services may affect company performance
  • Past performance does not guarantee future results for Health Sciences Acquisitions Corporation 2
  • Investors should consider how Health Sciences Acquisitions Corporation 2 fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

149.23M

P/E Ratio (TTM)

-532.40

Beta

0.00

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Financial Services Sector

The Financial Services sector includes companies that provide banking, insurance, investment, and other financial services to consumers and businesses.